awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
Graphs
1
Q37045504-1CF4416D-7D79-4702-93A3-3DC6BA240C17
Q37045504-1CF4416D-7D79-4702-93A3-3DC6BA240C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37045504-1CF4416D-7D79-4702-93A3-3DC6BA240C17
Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients.
P304
Q37045504-1CF4416D-7D79-4702-93A3-3DC6BA240C17
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37045504-1CF4416D-7D79-4702-93A3-3DC6BA240C17
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
187c2cfb0471f93bf004b0186ba1bbc19eba5741
P304
1013-1021
http://www.w3.org/2001/XMLSchema#string